All posts in Neuro
Zynex Announces New and Expanded Credit Agreement and Preliminary Fiscal Year 2009 Net Cash Balance
LITTLETON, Colo., Mar 22, 2010 (BUSINESS WIRE) -- Zynex, Inc. (ZYXI 0.79, -0.04, -4.27%), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces that Zynex, Inc. and its subsidiary, Zynex Medical, have entered into a new ...
Cleveland Clinic receives $1 million grant for spinal cord research
The Cleveland Clinic has received a $1 million federal grant to research treatments for spinal cord injuries. The National Institutes of Health grant will help lead investigator Yu-Shang Lee
Modified Adult Stem Cells May Be Helpful in Spinal Cord Injury
ScienceDaily (Feb. 24, 2010) — Researchers at UTHealth have demonstrated in rats that transplanting genetically modified adult stem cells into an injured spinal cord can help restore the electrical
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
HAWTHORNE, N.Y., Feb 22, 2010 (BUSINESS WIRE) -- Acorda Therapeutics, Inc. (ACOR 31.71, -0.23, -0.72%)announced today that Adrian L. Rabinowicz, M.D., FAAN, has joined the Company as
NeuroRepair Validates IP with Lab’s Success in New Stroke Therapy
Two recent studies by neuroscientists at the University of California, Irvine, have had startling success with a neuroregenerative therapy tested in rats. The therapy may eventually help restore
Neuro Kinetics Is Company ‘To Watch,’ Says Top Defense Publication
PITTSBURGH, Feb. 4 /PRNewswire/ -- Defense Technology International, an influential publication serving the defense and military markets, says medical device manufacturer Neuro Kinetics, Inc. (www.neuro-kinetics.com)
Celebrating 30 Years of Innovation in Neuromodulation, St. Jude Medical Unveils Latest Product at American Academy of Pain Medicine Annual Meeting
ST. PAUL, Minn., Feb 03, 2010 (BUSINESS WIRE) ----St. Jude Medical, Inc. (NYSE:STJ) today announced the U.S. Food and Drug Administration (FDA) clearance of the Swift-Lock(TM) anchor, a
Misonix Announces New Distribution Agreement for Brazil
FARMINGDALE, N.Y., Feb. 3 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced today that Lauren Sabella has joined the Company as Executive Vice President, Commercial Development, reporting to Ron Cohen, M.D., President
First U.S. stem cells transplanted into spinal cord
ATLANTA, Georgia (CNN) -- For the first time in the United States, stem cells have been directly injected into the spinal cord of a patient, researchers announced Thursday. Doctors
Perceptum Announces Faculty Development and Device Training for Physicians
| Company expands upon its extensive medical device training and education programs by offering faculty development and device training for physicians. |
AGH teams with Revita, Pneumex to on clinical trial for spinal device
Allegheny General Hospital is teaming withPneumex Inc. and its subsidiary, Revita Consumer Products LLC, to investigate non-surgical treatment options for spinal pain associated with nerve compression,
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Genesis™ spinal cord
Brain-Controlled Devices May Help Transcend Paralysis and Speech Problems
The vast popularity of the movie Avatar underscores the increasingly tangible future possibility of transcending paralysis by technological means. A recent article on CNN’s web site presented a
MiMedx Group Announces Launch of its Paradis Vaso Shield(TM) Device
ATLANTA, Dec. 23 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG.OB) announced today that it has officially launched its first product, Paradis Vaso Shield™. In April